Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $360.91M in the twelve months ending March 31, 2024, with 370.57% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.41M, a -69.39% decrease year-over-year. In the year 2023, Beam Therapeutics had annual revenue of $377.71M with 520.01% growth.

• Revenue (ttm): $360.91M
• Revenue Growth: +370.57%
• P/S Ratio: 5.15
• Revenue / Employee: $711,856
• Employees: 507
• Market Cap: 1.86B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	377.71M	316.79M	520.01%
Dec 31, 2022	60.92M	9.08M	17.51%
Dec 31, 2021	51.84M	51.82M	215,916.67%
Dec 31, 2020	24.00K	6.00K	33.33%
Dec 31, 2019	18.00K	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.